- $95.27bn
- $117.89bn
- $176.81bn
- 58
- 59
- 89
- 78
Annual balance sheet for Elevance Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-Q | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4,129 | 4,547 | 4,920 | 4,943 | 5,219 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Insurance Receivables | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Other Assets | |||||
Total Assets | 86,615 | 97,460 | 102,755 | 108,928 | 116,889 |
Accounts Payable | |||||
Accrued Expenses | |||||
Policy Liabilities | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 53,416 | 61,400 | 66,512 | 69,622 | 75,574 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 33,199 | 36,060 | 36,243 | 39,306 | 41,315 |
Total Liabilities & Shareholders' Equity | 86,615 | 97,460 | 102,755 | 108,928 | 116,889 |
Total Common Shares Outstanding |